Effect of Clofibrate Treatment and Withdrawal on Hepatic Iron Metabolism in Rat
碩士 === 國立臺灣大學 === 農業化學研究所 === 90 === Hypolipidemic drug clofibrate alters iron homeostasis, including decreased transferrin(Tf)mRNA and increased protein and activity of mitochondrial aconitase(m-ACO)in the liver. Since Tf mRNA is elevated and m-ACO is down-regulated by iron deficiency, clofibrate m...
Main Authors: | Yang-Li Wang, 王雅麗 |
---|---|
Other Authors: | 蕭寧馨 |
Format: | Others |
Language: | zh-TW |
Published: |
2002
|
Online Access: | http://ndltd.ncl.edu.tw/handle/48095065136684269751 |
Similar Items
-
The metabolism of clofibrate in man
by: Sedaghat, A.
Published: (1977) -
Effects of treatment with clofibrate, bezafibrate, and ciprofibrate on the metabolism of cholesterol in rat liver microsomes.
by: D Ståhlberg, et al.
Published: (1989-07-01) -
Effect of clofibrate and thyroid status on the metabolism of the perfused rat liver
by: Laker, M. E.
Published: (1979) -
Effects of Clofibrate on Salt Loading-Induced Hypertension in Rats
by: Antonio Cruz, et al.
Published: (2011-01-01) -
Influence of Dietary Lipids and Clofibrate on Iron Homeostasis and the Expression of Iron-Associated Proteins
by: Hui-Ling Huang, et al.
Published: (2001)